Effect of scopolamine butylbromide injection combined with tamsulosin oral auxiliary extracorporeal shock wave lithotripsy in the treatment of urinary calculi and influence on serum inflammatory factors
10.3760/cma.j.issn.1008-6706.2019.03.018
- VernacularTitle:丁溴东莨菪碱联合坦索罗辛辅助体外冲击波碎石治疗泌尿系结石的疗效及对血清炎性因子的影响
- Author:
Yuejun CHEN
1
Author Information
1. 浙江省
- Keywords:
Scopolamine hydrobromide;
Extracorporeal shock wave;
Tamsulosin;
Urinary calculi;
Gravel therapy;
Inflammatory cytokines
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(3):324-327
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of scopolamine butylbromide injection combined with tamsulosin oral auxiliary extracorporeal shock wave lithotripsy(ESWL) in the treatment of urinary calculi,and to investigate its effect on serum inflammatory factors.Methods From January 2016 to May 2017,96 patients with urinary calculi in the People's Hospital of Lanxi were selected and randomly divided into control group(n =42) and observation group(n =54).The control group received scopolamine butylbromide assisted ESWL treatment,the observation group treated with tamsulosin on the basis of the control group.The VAS score,clinical efficacy,adverse reactions and serum C reactive protein(CRP),tumor necrosis factor alpha(TNF-alpha) and other inflammatory factors were compared between the two groups.Results Before treatment,no statistically significant difference in VAS score was found between the two groups (t =0.274,P ＞ 0.05).After treatment,the VAS score of the observation group was (2.21 ± 0.28) points,which was significantly lower than that of the control group[(4.75 ± 0.63) points] (t =7.935,P ＜ 0.05).The stone clearance rate in the observation group was 96.30％ (52/54),which was significantly higher than that in the control group[71.43％ (30/42)] (x2 =6.712,P ＜ 0.05).The time of disappearance of pain in the observation group was (10.86 ± 1.54) d,which was significantly lower than that in the control group [(7.02 ± 1.25) d] (t =7.468,P ＜0.05).The lithecbole time of the observation group was (9.01 ± 1.53) h,which was significantly shorter than that of the control group[(13.25 ± 2.21) h] (t =8.035,P ＜ 0.05).Before treatment,there were no statistically significant differences in serum CRP and TNF-levels between the two groups (t =0.152,0.185,all P ＞0.05).After treatment,the serum level of CRP in the observation group was (11.64 ± 1.75) mg/L,which was significantly lower than that in the control group [(18.94 ± 2.03) mg/L] (t =7.008,P ＜ 0.05).After treatment,the serum TNF-level in the observation group was (13.95 ± 2.01)mg/L,which was significantly lower than that in the control group[(20.76 ±3.18) mg/L] (t =7.008,P ＜0.05).The incidence rate of adverse reactions of the observation group was 5.56％,which was significantly lower than 26.19％ of the control group (x2 =9.572,P ＜ 0.05).Conclusion Urinary calculi underwent intravenous infusion of scopolamine butylbromide combined with tamsulosin oral adjuvant ESWL therapy,can effectively reduce the pain of patients,reduce the serum levels of inflammatory cytokines,improve the stone clearance rate,and with less complications,it is worthy of clinical popularization and application.
